Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Feb 04, 2022	CORRESP	CORRESP	View HTML 0001628280-22-001856.pdf 0001628280-22-001856.rtf 0001628280-22-001856.xls
Feb 04, 2022	CORRESP	CORRESP	View HTML 0001628280-22-001855.pdf 0001628280-22-001855.rtf 0001628280-22-001855.xls
Feb 01, 2022	UPLOAD	UPLOAD	View HTML 0000000000-22-001311.pdf 0000000000-22-001311.rtf
Feb 01, 2022	UPLOAD	UPLOAD	View HTML 0000000000-22-001313.pdf 0000000000-22-001313.rtf
Jan 28, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001867096-22-000023.pdf 0001867096-22-000023.rtf 0001867096-22-000023.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 28, 2022	Simplified registration form	S-3	View HTML 0001628280-22-001447.pdf 0001628280-22-001447.rtf 0001628280-22-001447.xls
Jan 28, 2022	Simplified registration form	S-3	View HTML 0001628280-22-001449.pdf 0001628280-22-001449.rtf 0001628280-22-001449.xls
Jan 18, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001867096-22-000017.pdf 0001867096-22-000017.rtf 0001867096-22-000017.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 14, 2022	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0000935836-22-000016.pdf 0000935836-22-000016.rtf 0000935836-22-000016.xls
Jan 05, 2022	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0000919574-22-000042.pdf 0000919574-22-000042.rtf 0000919574-22-000042.xls

Data provided by Kaleidoscope.